halopemide

Suppliers

Names

[ Name ]:
halopemide

[Synonym ]:
halopemide ( N-<2-<4-(5-chloro-2-oxo-1-benzimidazolinyl)piperidino>ethyl>-p-fluorobenzamide )
Halopemidum
Halopemida
N-{2-[4-(5-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)-1-piperidinyl]ethyl}-4-fluorobenzamide
N-(2-(4-(5-Chloro-2-oxo-1-benzimidazolinyl)piperidino)ethyl)-p-fluorobenzamide
5-chloro-1-{1-[2-(4-fluoro-benzoylamino)-ethyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one
N-2-[4-(5-chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]ethyl-4-fluoro benzamide
N-{2-[4-(5-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]ethyl}-4-fluorobenzamide
R 34,301
Benzamide, N-[2-[4-(5-chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]ethyl]-4-fluoro-
halopemide
Halopemide (USAN/INN)
N-[2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]ethyl]-4-fluorobenzamide

Chemical & Physical Properties

[ Density]:
1.3±0.1 g/cm3

[ Molecular Formula ]:
C₂₁H₂₂ClFN₄O₂

[ Molecular Weight ]:
416.876

[ Exact Mass ]:
416.141541

[ PSA ]:
70.13000

[ LogP ]:
4.47

[ Index of Refraction ]:
1.612

[ Storage condition ]:
2-8°C

MSDS

Click to get detail MSDS

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H302

[ Hazard Codes ]:
Xn

[ RIDADR ]:
NONH for all modes of transport

Articles

CAY10593 inhibits the human P2X7 receptor independently of phospholipase D1 stimulation.

Purinergic Signal. 9(4) , 609-19, (2013)

The P2X7 receptor is a trimeric ATP-gated cation channel important in health and disease. We have observed that the specific phospholipase D (PLD)1 antagonist, CAY10593 impairs P2X7-induced shedding o...

Halopemide, a new psychotropic agent. Cerebral distribution and receptor interactions.

Pharm. Weekbl. Sci. 7(1) , 1-9, (1985)

Halopemide is a new psychotropic agent, a structural analogue of the neuroleptics of the butyrophenone type but with different pharmacological and clinical properties. Preliminary clinical findings in...

Dynamic cation-exchange systems for the separation of drugs derived from butyrophenone and diphenylpiperidine by high-performance liquid chromatography and applied in the determination of halopemide in plasma.

J. Chromatogr. A. 164(2) , 177-85, (1979)

Dynamic (solvent generated) cation-exchange systems for the separation of drugs and main metabolites derived from butyrophenone and diphenylpiperidine (haloperidol, pimozide, halopemide) were investig...

1-[(Benzyloxy)carbonyl]-3-(3-fluorophenyl)pyrrolidine-2-carboxylic acid
Methyl 2,2-dioxo-2lambda6-thia-8-azaspiro[4.5]decane-4-carboxylate
4-{[(Benzyloxy)carbonyl]amino}-2-fluoro-3-methylbutanoic acid
1-(cyclopropylmethyl)-4-[(pyrrolidin-2-yl)methyl]-1H-1,2,3-triazole
4-Bromo-2-methoxyphenyl sulfamate
2-{[(Benzyloxy)carbonyl]amino}indolizine-1-carboxylic acid
(3R)-2-[(benzyloxy)carbonyl]-7,7-difluoro-2-azabicyclo[4.1.0]heptane-3-carboxylic acid
2-Methoxythiophene-3-sulfonyl fluoride
6-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-5-methoxypyridine-2-carboxylic acid
5-({[(Benzyloxy)carbonyl]amino}methyl)-5-methyl-4,5-dihydro-1,2-oxazole-3-carboxylic acid

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.